Blueprint Medicines Corp
(BPMC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2014 | 12-2013 | 12-2006 | |
| Operating Expenses | 39,734 | 21,000 | 0 |
| Operating Income | -39,734 | -21,000 | N/A |
| Interest Expense | 453 | 138 | 0 |
| Other Income | -98 | 226 | 0 |
| Pre-tax Income | -40,285 | -20,912 | 0 |
| Net Income Continuous | -40,285 | -20,912 | N/A |
| Net Income | $-40,285 | $-20,912 | $N/A |
| EPS Basic Total Ops | -32.41 | -23.43 | N/A |
| EPS Basic Continuous Ops | -28.35 | -20.60 | N/A |
| EPS Diluted Total Ops | -32.41 | -23.43 | N/A |
| EPS Diluted Continuous Ops | -28.35 | -20.60 | N/A |
| EBITDA(a) | $-39,112 | $-20,499 | $N/A |